|
|
 | | | |
- close
- close
- close
- close
Eaton Vance Tax Advantaged Dividend Income Fund (EVT) |
Forbes
Mar 11
Comment
On 3/13/13, Economic Investment Trust Limited (Toronto: EVT) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 3/28/13. As a percentage of EVT's recent stock price of $65.20, this dividend works out to approximately...
Forbes
Sep 10
Comment
On 9/12/12, Economic Investment Trust Limited (Toronto: EVT) will trade ex-dividend, for its quarterly dividend of $0.15, payable on 9/28/12. As a percentage of EVT's recent stock price of $55.00, this dividend works out to approximately...
Forbes
Jun 29
Comment
In trading on Friday, shares of Economic Investment Trust Limited (Toronto: EVT) crossed below their 200 day moving average of $55.33, changing hands as low as $54.25 per share. Economic Investment Trust Limited shares are currently trading down...
Globe Newswire
May 2
Comment
License Granted to One of the Largest Pharmaceutical Companies in China Development of Evotec Proprietary Compound EVT 401 Intended for Inflammatory Diseases Upfront, Approx. € 60 Mio Milestones and Tiered Double-Digit Royalties HAMBURG, Germany,
Globe Newswire
Aug 11
Comment
HAMBURG, Germany, Aug. 11, 2011 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced that it has entered into a world-wide license and collaboration agreement with a top tier animal health company that intends to develop the
Globe Newswire
Jul 1
Comment
HAMBURG, Germany, July 1, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced the start of the proof-of-concept Phase II study in treatment-resistant depression with its NR2B subtype selective NMDA receptor antagonist EVT 101.
Globe Newswire
Mar 10
Comment
Successful completion of first-in-man study with EVT 103 Positive feedback from the FDA to initiate Phase II with EVT 101 HAMBURG, Germany, March 10, 2010 (GLOBE NEWSWIRE) -- Evotec AG (Frankfurt:EVT) (TecDAX) today announced two positive aspects
StreetInsider.com
Sep 9
Comment
Visit StreetInsider.com at http://www.streetinsider.com/FDA/Evotec+%28EVT%29+Announces+Research+Agreement+With+Biogen+Idec+%28BIIB%29/4929525.html for the full story.
Wall Street Journal
Jun 11
Comment
With inflation possibly ahead, hold off on CDs and Treasurys, but muni bonds may be a bright spot, writes Brett Arends.
Restaurant at the End of the Universe
Apr 24
Comment
WSJ is out recommending EVT today as it pays a 7% dividend and trades at discount on NAV because of ARPS issues, but I have my reservations.
This is an equity close-ended fund. None of the big stocks that this fund owns has a 7% yield. So the...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
